Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
145 studies found for:    "Pharmacologic Actions"
Show Display Options
Rank Status Study
1 Recruiting The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
Condition: The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
Intervention: Drug: Psilocybin
2 Recruiting Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
Condition: Healthy
Intervention: Drug: Psilocybin
3 Completed
Has Results
Prasugrel/Clopidogrel Maintenance Dose Washout Study
Condition: Coronary Artery Disease
Interventions: Drug: prasugrel;   Drug: clopidogrel
4 Recruiting Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: Rosuvastatin
5 Completed
Has Results
Efficacy of Nalmefene in Patients With Alcohol Dependence
Condition: Alcohol Dependence
Interventions: Drug: Placebo;   Drug: Nalmefene
6 Completed
Has Results
Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence
Condition: Alcohol Dependence
Interventions: Drug: Placebo;   Drug: Nalmefene
7 Completed University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease;   Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone;   Drug: Placebo
8 Recruiting High-dose Vitamin D Supplementation for ADT-induced Side Effects
Conditions: Prostatic Neoplasms;   Bone Mineral Density Quantitative Trait Locus 3
Interventions: Dietary Supplement: vitamin D;   Dietary Supplement: Placebo
9 Withdrawn Influence of Atorvastatin on Psoriasis Severity and Endothelial Function
Condition: Psoriasis
Interventions: Drug: Atorvastatin;   Drug: Atorvastatin placebo
10 Recruiting Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Condition: Healthy
Interventions: Drug: Moderately-high dose of psilocybin;   Drug: Moderately-low dose of psilocybin;   Drug: Very-low dose of psilocybin;   Drug: Placebo
11 Completed Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Conditions: Psilocybin;   Hallucinogens;   Pharmacologic Actions;   Central Nervous System Agents;   Therapeutic Uses;   Psychotropic Drugs
Intervention: Drug: psilocybin
12 Completed A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants
Condition: Healthy Adult Females
Interventions: Drug: Tenofovir;   Drug: Maraviroc
13 Unknown  Docetaxel Lipid Microsphere (DT-LM) for Injection in Chemotherapy Patients
Condition: Advanced Cancer
Interventions: Drug: DT-LM;   Drug: docetaxel
14 Active, not recruiting Aspirin Response in High Risk Patients With Coronary Artery Disease
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Diabetes Mellitus;   Renal Insufficiency, Chronic
Intervention:
15 Completed Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults
Condition: Colonoscopy
Intervention: Drug: Crystalline Lactulose
16 Completed
Has Results
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection
Condition: Clostridium Difficile Infection
Interventions: Biological: VP20621;   Other: Placebo
17 Completed Custodiol-HTK Solution as a Cardioplegic Agent
Conditions: Coronary Artery Disease;   Myocardial Ischemia;   Coronary Disease;   Heart Diseases;   Valvular Heart Disease
Interventions: Drug: Custodiol HTK;   Drug: Cold Blood Cardioplegia
18 Active, not recruiting Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
Conditions: Traumatic Brain Injury;   Cognitive Impairment
Intervention: Drug: Rivastigmine Transdermal Patch
19 Completed A Trial of Tadalafil and Glycemic Traits
Conditions: Cardiovascular Disease;   Insulin Resistance;   Glucose Intolerance;   Obesity
Interventions: Drug: Tadalafil;   Drug: Placebo
20 Recruiting An Observational Study to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With Iclusig®
Condition: Myeloid Leukemia, Chronic, Chronic-Phase
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.